First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part
Cancer（2023）
摘要
E7130 480 μg/m Q3W was chosen for the dose-expansion part over 300 μg/m Q2W primarily per dose-dependent biomarker results.
更多查看译文
关键词
E7130,biomarker,first-in-human,halichondrin,tumor microenvironment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要